SPIROGEN
Spirogen is a clinical stage biotechnology company specialising in novel, sequence-selective, DNA minor groove-binding molecules with potent therapeutic properties. Spirogen's principal technology involves modification of members of a group of naturally occurring antibiotics called pyrrolobenzodiazepines (PBDs). The company was founded in 2000, has 18 employees and is private equity funded.
SPIROGEN
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.spirogen.com
Total Employee:
101+
Status:
Active
Contact:
44 (0) 20 7278 0555
Email Addresses:
[email protected]
Total Funding:
16.43 M USD
Technology used in webpage:
SSL By Default Content Delivery Network Amazon Microsoft Azure DNS Amazon Route 53 Sectigo SSL Amazon CloudFront Mimecast GlobalSign Domain Verification Amazon Elastic Load Balancing Sticky Session
Similar Organizations
CellServe GmbH
CellServe is Berlin-based biotechnology company that specializes in regenerative medicine.
Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Current Employees Featured
Investors List
Auven Therapeutics
Auven Therapeutics investment in Private Equity Round - Spirogen
Cambridge Research & Innovation Ltd.
Cambridge Research & Innovation Ltd. investment in Seed Round - Spirogen
Official Site Inspections
http://www.spirogen.com
- Host name: server-18-154-227-14.iad55.r.cloudfront.net
- IP address: 18.154.227.14
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
